science
plus
.abes.fr
|
explorer
À propos de :
Brasili L.
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
foaf:Person
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Person
New Facet based on Instances of this Class
Attributs
Valeurs
type
Person
name
Brasili L.
Brasili Livio
familyName
Brasili
Given name
L.
Livio
is
relates
of
http://hub.abes.fr/acs/periodical/jmcmar/1985/volume_28/issue_11/101021jm00149a017/authorship/2
http://hub.abes.fr/acs/periodical/jmcmar/1988/volume_31/issue_12/101021jm00120a009/authorship/2
http://hub.abes.fr/acs/periodical/jmcmar/1999/volume_42/issue_15/101021jm991049m/authorship/11
http://hub.abes.fr/acs/periodical/jmcmar/2002/volume_45/issue_1/101021jm0110082/authorship/3
http://hub.abes.fr/acs/periodical/jmcmar/2003/volume_46/issue_11/101021jm021113r/authorship/3
http://hub.abes.fr/acs/periodical/jmcmar/1998/volume_41/issue_10/101021jm970740r/authorship/5
http://hub.abes.fr/acs/periodical/jmcmar/2003/volume_46/issue_8/101021jm021078o/authorship/1
http://hub.abes.fr/acs/periodical/jmcmar/1985/volume_28/issue_9/101021jm00147a042/authorship/4
http://hub.abes.fr/acs/periodical/jmcmar/1988/volume_31/issue_9/101021jm00117a007/authorship/4
http://hub.abes.fr/acs/periodical/jmcmar/1989/volume_32/issue_1/101021jm00121a017/authorship/5
http://hub.abes.fr/acs/periodical/jmcmar/1988/volume_31/issue_9/101021jm00117a006/authorship/5
http://hub.abes.fr/acs/periodical/jmcmar/1984/volume_27/issue_12/101021jm00378a001/authorship/2
http://hub.abes.fr/acs/periodical/jmcmar/1986/volume_29/issue_9/101021jm00159a009/authorship/4
http://hub.abes.fr/acs/periodical/jmcmar/1988/volume_31/issue_9/101021jm00117a030/authorship/2
http://hub.abes.fr/acs/periodical/jmcmar/1989/volume_32/issue_1/101021jm00121a011/authorship/2
http://hub.abes.fr/springer/periodical/210/1990/volume_342/issue_6/B963531A75595AEAE053120B220A32E0/authorship/2
http://hub.abes.fr/acs/periodical/jmcmar/1987/volume_30/issue_10/101021jm00393a042/authorship/4
is
Author
of
Molecular requirements of the recognition site of cholinergic receptors. 27. Enantioselectivity of muscarinic antagonists. 2,2-Dicyclohexyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides and related 3-oxides
2-[[[2-(2,6-Dimethoxyphenoxy)ethyl]amino]methyl]-1,4-benzoxathian: a new antagonist with high potency and selectivity towards .alpha.1-adrenoreceptors
Structure-activity relationships among methoctramine-related polymethylenetetramines. Chain length and substituent effects on M-2 muscarinic receptor blocking activity
Determination of muscarinic agonist potencies at M1 and M2 muscarinic receptors in a modified pithed rat preparation
Structure-activity relationships among benextramine-related tetraamine disulfides at peripheral .alpha.-adrenoreceptors
Molecular requirements of the recognition site of the cholinergic receptor. 24. Resolution, absolute configuration, and cholinergic enantioselectivity of (-)- and (+)-c-2-methyl-r-5-[(dimethylamino)methyl]-1,3-oxathiolane t-3-oxide methiodide and related sulfones
Structure-activity relationships among benextramine-related tetraamine disulfides. Chain length effect on .alpha.-adrenoreceptor blocking activity
2-(2-Phenylcyclopropyl)imidazolines: Reversed Enantioselective Interaction atI1 and I2 Imidazoline Receptors
α2-Adrenoreceptors Profile Modulation and High Antinociceptive Activity of(S)-(−)-2-[1-(Biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole
1,3-Dioxolane-Based Ligands as a Novel Class of α1-Adrenoceptor Antagonists
1‘-Benzyl-3,4-dihydrospiro[2H-1-benzothiopyran-2,4‘-piperidine](Spipethiane), a Potent and HighlySelective σ1 Ligand
Imidazoline Binding Sites (IBS) Profile Modulation: Key Role of the Bridge inDetermining I1-IBS or I2-IBS Selectivity within a Series of2-Phenoxymethylimidazoline Analogues
Structure-activity relationships for prazosin and WB 4101 analogs as .alpha.1-adrenoreceptor antagonists
Molecular requirements of the recognition site of cholinergic receptors. 22. Resolution, absolute configuration, and cholinergic enantioselectivity of (+)- and (-)-cis-2-methyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodide
Structure-activity relationships in 1,4-benzodioxan-related compounds. Investigation on the role of the dehydrodioxane ring on .alpha.1-adrenoreceptor blocking activity
Molecular requirements of the recognition site of cholinergic receptors. 28. Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides
Structure-activity relationships in prazosin-related compounds. Effect of replacing a piperazine ring with an alkanediamine moiety on .alpha.1-adrenoreceptor blocking activity
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
